In the BioHarmony Drug Report Database

"Preview" Icon

Bosentan

Tracleer (bosentan) is a small molecule pharmaceutical. Bosentan was first approved as Tracleer on 2001-11-20. It is used to treat pulmonary hypertension in the USA. It has been approved in Europe to treat pulmonary hypertension and systemic scleroderma. The pharmaceutical is active against endothelin receptor type B. In addition, it is known to target endothelin-1 receptor. Tracleer’s patent is valid until 2027-12-28 (FDA).

 

Trade Name

 

Tracleer
 

Common Name

 

bosentan
 

ChEMBL ID

 

CHEMBL957
 

Indication

 

pulmonary hypertension, systemic scleroderma
 

Drug Class

 

Endothelin receptor antagonists

Image (chem structure or protein)

Bosentan structure rendering